This process from beginning to end has been a very well organized program as seen through the eyes of a concerned pet parent. Once the program is paid, Gallant goes to work. The Gallant team's schedule is quite knowledgable and answers all of your questions.The promotional material via speaking to a live person has been remarkable. Hard copies of detailed information was provided, again, via concerned made our decision even more quickly, The incentive to possibly extend our furbaby's life, and generate newer cells is a gift to your pet's health for you and your pet who has been a family member for years.
Claim your business profile now and gain access to all features and respond to customer reviews.
Gallant is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing, and commercialization.See more
